Data regarding acute overdose of nandrolone decanoate are not readily available.L9464 However, patients experiencing a chronic overdose of anabolic steroids may experience adverse effects including suppression of testosterone and spermatogenesis, shrinking of testicles, decreased libido, and erectile dysfunction in men; and suppressed estrogen, progesterone, and ovulation, amenorrhea, and clitoromegaly in women.A233789 Patients may also experience neuropsychiatric, cardiovascular, and hepatic adverse effects.A233789 Alkylated anabolic steroids such as nandrolone decanoate are more likely to cause hepatic adverse effects.A233789 Treat patients with symptomatic and supportive measures.
The intraperitoneal LD50 in mice is >566 mg/kg.L33229
Nandrolone decanoate, also known as nandrolone caprinate, is an alkylated anabolic steroid indicated in the management of anemia of renal insufficiency and as an adjunct therapy in the treatment of senile and postmenopausal osteoporosis.A233789,A233849,L32564,L9464 The process for creating esters of nandrolone was patented in Spain in 1959L33244 and in 1960, it was described as having a long duration of action and strong anabolic effect compared to nandrolone and other esters.A233849
Nandrolone decanoate was granted FDA approval on 5 October 1962.L32564
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Cyclosporine | The risk or severity of liver damage can be increased when Nandrolone decanoate is combined with Cyclosporine. |
| Dicoumarol | Nandrolone decanoate may increase the anticoagulant activities of Dicoumarol. |
| Phenindione | Nandrolone decanoate may increase the anticoagulant activities of Phenindione. |
| Warfarin | Nandrolone decanoate may increase the anticoagulant activities of Warfarin. |
| Phenprocoumon | Nandrolone decanoate may increase the anticoagulant activities of Phenprocoumon. |
| Acenocoumarol | Nandrolone decanoate may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Nandrolone decanoate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | Nandrolone decanoate may increase the anticoagulant activities of Coumarin. |
| (R)-warfarin | Nandrolone decanoate may increase the anticoagulant activities of (R)-warfarin. |
| Ethyl biscoumacetate | Nandrolone decanoate may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Fluindione | Nandrolone decanoate may increase the anticoagulant activities of Fluindione. |
| Clorindione | Nandrolone decanoate may increase the anticoagulant activities of Clorindione. |
| Diphenadione | Nandrolone decanoate may increase the anticoagulant activities of Diphenadione. |
| Tioclomarol | Nandrolone decanoate may increase the anticoagulant activities of Tioclomarol. |
| (S)-Warfarin | Nandrolone decanoate may increase the anticoagulant activities of (S)-Warfarin. |
| Insulin human | Nandrolone decanoate may increase the hypoglycemic activities of Insulin human. |
| Insulin lispro | Nandrolone decanoate may increase the hypoglycemic activities of Insulin lispro. |
| Insulin glargine | Nandrolone decanoate may increase the hypoglycemic activities of Insulin glargine. |
| Insulin pork | Nandrolone decanoate may increase the hypoglycemic activities of Insulin pork. |
| Troglitazone | Nandrolone decanoate may increase the hypoglycemic activities of Troglitazone. |
| Glimepiride | Nandrolone decanoate may increase the hypoglycemic activities of Glimepiride. |
| Sulfisoxazole | Nandrolone decanoate may increase the hypoglycemic activities of Sulfisoxazole. |
| Disopyramide | Nandrolone decanoate may increase the hypoglycemic activities of Disopyramide. |
| Acarbose | Nandrolone decanoate may increase the hypoglycemic activities of Acarbose. |
| Metformin | Nandrolone decanoate may increase the hypoglycemic activities of Metformin. |
| Sulfadiazine | Nandrolone decanoate may increase the hypoglycemic activities of Sulfadiazine. |
| Rosiglitazone | Nandrolone decanoate may increase the hypoglycemic activities of Rosiglitazone. |
| Acetohexamide | Nandrolone decanoate may increase the hypoglycemic activities of Acetohexamide. |
| Quinine | Nandrolone decanoate may increase the hypoglycemic activities of Quinine. |
| Miglitol | Nandrolone decanoate may increase the hypoglycemic activities of Miglitol. |
| Chlorpropamide | Nandrolone decanoate may increase the hypoglycemic activities of Chlorpropamide. |
| Nateglinide | Nandrolone decanoate may increase the hypoglycemic activities of Nateglinide. |
| Pentamidine | Nandrolone decanoate may increase the hypoglycemic activities of Pentamidine. |
| Mifepristone | Nandrolone decanoate may increase the hypoglycemic activities of Mifepristone. |
| Tolazamide | Nandrolone decanoate may increase the hypoglycemic activities of Tolazamide. |
| Repaglinide | Nandrolone decanoate may increase the hypoglycemic activities of Repaglinide. |
| Phenformin | Nandrolone decanoate may increase the hypoglycemic activities of Phenformin. |
| Sulfamethoxazole | Nandrolone decanoate may increase the hypoglycemic activities of Sulfamethoxazole. |
| Glyburide | Nandrolone decanoate may increase the hypoglycemic activities of Glyburide. |
| Glipizide | Nandrolone decanoate may increase the hypoglycemic activities of Glipizide. |
| Gliclazide | Nandrolone decanoate may increase the hypoglycemic activities of Gliclazide. |
| Tolbutamide | Nandrolone decanoate may increase the hypoglycemic activities of Tolbutamide. |
| Pioglitazone | Nandrolone decanoate may increase the hypoglycemic activities of Pioglitazone. |
| Bromocriptine | Nandrolone decanoate may increase the hypoglycemic activities of Bromocriptine. |
| Gliquidone | Nandrolone decanoate may increase the hypoglycemic activities of Gliquidone. |
| Mitiglinide | Nandrolone decanoate may increase the hypoglycemic activities of Mitiglinide. |
| Sitagliptin | Nandrolone decanoate may increase the hypoglycemic activities of Sitagliptin. |
| Sunitinib | Nandrolone decanoate may increase the hypoglycemic activities of Sunitinib. |
| Exenatide | Nandrolone decanoate may increase the hypoglycemic activities of Exenatide. |
| Mecasermin | Nandrolone decanoate may increase the hypoglycemic activities of Mecasermin. |
| Pramlintide | Nandrolone decanoate may increase the hypoglycemic activities of Pramlintide. |
| Glisoxepide | Nandrolone decanoate may increase the hypoglycemic activities of Glisoxepide. |
| Insulin aspart | Nandrolone decanoate may increase the hypoglycemic activities of Insulin aspart. |
| Insulin detemir | Nandrolone decanoate may increase the hypoglycemic activities of Insulin detemir. |
| Insulin glulisine | Nandrolone decanoate may increase the hypoglycemic activities of Insulin glulisine. |
| Glymidine | Nandrolone decanoate may increase the hypoglycemic activities of Glymidine. |
| AICA ribonucleotide | Nandrolone decanoate may increase the hypoglycemic activities of AICA ribonucleotide. |
| Buformin | Nandrolone decanoate may increase the hypoglycemic activities of Buformin. |
| Vildagliptin | Nandrolone decanoate may increase the hypoglycemic activities of Vildagliptin. |
| Voglibose | Nandrolone decanoate may increase the hypoglycemic activities of Voglibose. |
| NN344 | Nandrolone decanoate may increase the hypoglycemic activities of NN344. |
| AMG-222 | Nandrolone decanoate may increase the hypoglycemic activities of AMG-222. |
| Bisegliptin | Nandrolone decanoate may increase the hypoglycemic activities of Bisegliptin. |
| Alogliptin | Nandrolone decanoate may increase the hypoglycemic activities of Alogliptin. |
| Dapagliflozin | Nandrolone decanoate may increase the hypoglycemic activities of Dapagliflozin. |
| Saxagliptin | Nandrolone decanoate may increase the hypoglycemic activities of Saxagliptin. |
| Liraglutide | Nandrolone decanoate may increase the hypoglycemic activities of Liraglutide. |
| Gosogliptin | Nandrolone decanoate may increase the hypoglycemic activities of Gosogliptin. |
| Linagliptin | Nandrolone decanoate may increase the hypoglycemic activities of Linagliptin. |
| Canagliflozin | Nandrolone decanoate may increase the hypoglycemic activities of Canagliflozin. |
| Glibornuride | Nandrolone decanoate may increase the hypoglycemic activities of Glibornuride. |
| Benfluorex | Nandrolone decanoate may increase the hypoglycemic activities of Benfluorex. |
| Empagliflozin | Nandrolone decanoate may increase the hypoglycemic activities of Empagliflozin. |
| Albiglutide | Nandrolone decanoate may increase the hypoglycemic activities of Albiglutide. |
| Dulaglutide | Nandrolone decanoate may increase the hypoglycemic activities of Dulaglutide. |
| Lobeglitazone | Nandrolone decanoate may increase the hypoglycemic activities of Lobeglitazone. |
| Netoglitazone | Nandrolone decanoate may increase the hypoglycemic activities of Netoglitazone. |
| Rivoglitazone | Nandrolone decanoate may increase the hypoglycemic activities of Rivoglitazone. |
| Ciglitazone | Nandrolone decanoate may increase the hypoglycemic activities of Ciglitazone. |
| Lixisenatide | Nandrolone decanoate may increase the hypoglycemic activities of Lixisenatide. |
| Insulin beef | Nandrolone decanoate may increase the hypoglycemic activities of Insulin beef. |
| Insulin degludec | Nandrolone decanoate may increase the hypoglycemic activities of Insulin degludec. |
| Insulin peglispro | Nandrolone decanoate may increase the hypoglycemic activities of Insulin peglispro. |
| Insulin tregopil | Nandrolone decanoate may increase the hypoglycemic activities of Insulin tregopil. |
| Ipragliflozin | Nandrolone decanoate may increase the hypoglycemic activities of Ipragliflozin. |
| Dutogliptin | Nandrolone decanoate may increase the hypoglycemic activities of Dutogliptin. |
| Allicin | Nandrolone decanoate may increase the hypoglycemic activities of Allicin. |
| Tofogliflozin | Nandrolone decanoate may increase the hypoglycemic activities of Tofogliflozin. |
| Ertugliflozin | Nandrolone decanoate may increase the hypoglycemic activities of Ertugliflozin. |
| 2,4-thiazolidinedione | Nandrolone decanoate may increase the hypoglycemic activities of 2,4-thiazolidinedione. |
| Teneligliptin | Nandrolone decanoate may increase the hypoglycemic activities of Teneligliptin. |
| Omarigliptin | Nandrolone decanoate may increase the hypoglycemic activities of Omarigliptin. |
| Carmegliptin | Nandrolone decanoate may increase the hypoglycemic activities of Carmegliptin. |
| Gemigliptin | Nandrolone decanoate may increase the hypoglycemic activities of Gemigliptin. |
| Anagliptin | Nandrolone decanoate may increase the hypoglycemic activities of Anagliptin. |
| Evogliptin | Nandrolone decanoate may increase the hypoglycemic activities of Evogliptin. |
| Sotagliflozin | Nandrolone decanoate may increase the hypoglycemic activities of Sotagliflozin. |
| Balaglitazone | Nandrolone decanoate may increase the hypoglycemic activities of Balaglitazone. |
| Remogliflozin etabonate | Nandrolone decanoate may increase the hypoglycemic activities of Remogliflozin etabonate. |
| Carbutamide | Nandrolone decanoate may increase the hypoglycemic activities of Carbutamide. |